Dr Jelle Klein graduated as Medical Doctor in 2016 from the University of Antwerp with a Master of Science in Medicine. Prior to this, he received a Bachelor of Health from the Hanzehogeschool in Groningen in 2009. In 2024 he was board-certified as a specialist in Clinical Pharmacology and Pharmaceutical Medicine. Dr Klein joined the SGS Phase I unit as Principal Investigator, gaining experience in the coordination and set-up of phase 0-IV clinical trials (in different areas as immunology, dermatology, cardiology, etc.) while being responsible of the safety and wellbeing of the subjects on site as well as the analysis of the clinical data. Mid 2021, Dr Klein assumed the responsibility as Associate Medical Director at SGS CPU, supporting the CPU Medical Director in the creation of strategies supporting business innovations, specialization in therapeutic area of focus. Since mid-2022, he is CPU Medical Director, and overall responsible for medical and scientific aspects of the CPU early phase projects.